PROCEPT BioRobotics Corporation (PRCT) Financial Statements (2023 and earlier)

Company Profile

Business Address 900 ISLAND DRIVE
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments180,972221,859249,217269,806284,288304,320
Cash and cash equivalents180,972221,859249,217269,806284,288304,320
Restricted cash and investments3,8153,8153,8143,814 777
Receivables20,64215,27212,83810,8946,9924,464
Inventory, net of allowances, customer advances and progress billings38,92628,54322,35813,77712,62913,147
Inventory38,92628,54322,35813,77712,62913,147
Prepaid expense     2,8482,984
Other undisclosed current assets1,2253,137705461,222481
Total current assets:245,580272,626288,932298,337307,979326,173
Noncurrent Assets
Operating lease, right-of-use asset22,44623,48124,4242,4632,8773,279
Property, plant and equipment11,9348,6565,1204,3974,5605,045
Intangible assets, net (including goodwill), including:1,4091,4771,5451,6141,6821,750
Intangible assets, net (excluding goodwill)  (1,000)(1,000)(900)(900)(800)
Other undisclosed intangible assets, net (including goodwill)1,4092,4772,5452,5142,5822,550
Restricted cash and investments3,0383,0383,8143,8143,814777
Other noncurrent assets5151202302  
Total noncurrent assets:38,87836,70335,10512,59012,93310,851
TOTAL ASSETS:284,458309,329324,037310,927320,912337,024
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,74922,83816,61510,2487,2148,504
Employee-related liabilities10,2846,9064,5866,475
Accounts payable10,3419,3916,3313,3422,6282,029
Accrued liabilities7,40813,447    
Deferred revenue3,9432,8552,3421,8631,3681,025
Other liabilities7,8147,4685,9294,2643,9944,608
Other undisclosed current liabilities2,9982,1292,4732,2582,1812,105
Total current liabilities:32,50435,29027,35918,63314,75716,242
Noncurrent Liabilities
Long-term debt and lease obligation51,24151,21374,10751,33651,67251,995
Long-term debt, excluding current maturities51,24151,21350,69250,50750,25450,004
Liabilities, other than long-term debt27,58725,7541,8091,7701,7331,696
Deferred revenue      
Other liabilities   200200200200
Operating lease, liability25,78223,97523,4158291,4181,991
Derivative instruments and hedges, liabilities1,8051,7791,6091,5701,5331,496
Total noncurrent liabilities:78,82876,96775,91653,10653,40553,691
Total liabilities:111,332112,257103,27571,73968,16269,933
Equity
Equity, attributable to parent173,126197,072220,762239,188252,750267,091
Additional paid in capital550,270545,753541,048537,046531,509528,666
Accumulated other comprehensive income (loss)15(6)21732(53)(54)
Accumulated deficit(377,159)(348,675)(320,503)(297,890)(278,706)(261,521)
Total equity:173,126197,072220,762239,188252,750267,091
TOTAL LIABILITIES AND EQUITY:284,458309,329324,037310,927320,912337,024

Income Statement (P&L) ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
Revenues24,40423,77720,34916,69114,19710,138
Cost of revenue(11,913)(13,101)(10,118)(8,205)(6,505)(5,622)
Gross profit:12,49110,67610,2318,4867,6924,516
Operating expenses(40,868)(35,716)(32,336)(26,361)(23,396)(21,347)
Operating loss:(28,377)(25,040)(22,105)(17,875)(15,704)(16,831)
Nonoperating expense     (60)(63)
Other nonoperating expense     (59)(67)
Interest and debt expense(886)(4,124)(1,455)(1,441)(1,421)(1,440)
Other undisclosed income from continuing operations before equity method investments, income taxes  2,011    
Loss from continuing operations:(29,263)(27,153)(23,560)(19,316)(17,185)(18,334)
Loss before gain (loss) on sale of properties:(23,560)(19,316)(17,185)(18,334)
Net loss:(29,263)(27,153)(23,560)(19,316)(17,185)(18,334)
Other undisclosed net income (loss) attributable to parent779(1,019)947132 (14)
Net loss available to common stockholders, diluted:(28,484)(28,172)(22,613)(19,184)(17,185)(18,348)

Comprehensive Income ($ in thousands)

6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
Net loss:(29,263)(27,153)(23,560)(19,316)(17,185)(18,334)
Comprehensive loss:(29,263)(27,153)(23,560)(19,316)(17,185)(18,334)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent800(1,242)1,1322171(27)
Comprehensive loss, net of tax, attributable to parent:(28,463)(28,395)(22,428)(19,099)(17,184)(18,361)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: